FDA approves at-home tests for common sexually transmitted diseases

FDA-approved at-home tests for common STDs like gonorrhea and chlamydia are now available. This offers increased convenience and accessibility for testing and treatment. The agency also approved two new gonorrhea drugs, the first in decades, and home-based kits for HPV. Experts hope these advancements will help reduce STD infection rates. These developments follow a trend of increased STD screening and treatment options, aiming to combat rising infection rates seen during the COVID-19 pandemic.